http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106267422-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0413 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3633 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3672 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3687 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0781 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 |
| filingDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106267422-B |
| titleOfInvention | Rh blood group incompatibility haemolysis disease therapeutic apparatus |
| abstract | The present invention relates to the Rh blood group incompatibility haemolysis disease therapeutic apparatus of medical domain, it is characterized in that alternately washing the rhesus monkey erythrocytes containing the common Rh antigen of the mankind with the PB lysate that osmotic concentration is 25 and 35mmol/L, it is made and has dialysed hemoglobin but retained the antigenic ghost that can adsorb Rh antibody of Rh, it is fixed on the agarose of special concentration with specific proportion jointly with the anti-Rh antibody prepared with immunology, followed by assemble cylindrical adsorption device made of high-biocompatibility material, it is allowed to form antibody titer from high to low from sample introduction end to sample outlet end and agarose concentration but ghost from low to high is to be uniformly distributed, and nearly sample outlet end due to concentration is gradually high molecule micropore gradually the agarose of small special concentration and the mesh screen in absorber exit can the hematoclasis of effectively detention haemolysis patient produce Object is that one kind only removes pathogenic antibody, does not remove the treatment new method for the female tire Rh blood group incompatibility Hemolysis of blood plasma components having no toxic side effect. |
| priorityDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.